Announced
Financials
Sources
Tags
Single Bidder
United States
Majority
Private
Pending
bone graft products
Acquisition
Medical Supplies
Friendly
Cross Border
Synopsis
Halma, a safety, health and environmental technology group, agreed to acquire NovaBone Products, a designer and manufacturer of US FDA-approved synthetic bone graft products, for $122m, including a $25m earn-out consideration. "NovaBone extends our Medical sector's presence in surgical applications, adding a new niche within the orthopedics market, which is growing fast due to the ageing population and increasingly sedentary lifestyles causing joint problems. It has strong technology and knowhow within the fast-growing biologics segment, developing biomaterials that harnesses the body's natural healing process to accelerate bone growth," Andrew Williams, Halma Group Chief Executive.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.